Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Minaris Enhances GMP Cell Banking Suites at Philadelphia Facility
Thursday, June 18, 2026
Minaris announced the enhancement of its dedicated GMP cell banking suites at its Philadelphia facility, a centralized hub for cell banking and ... read more
Alcami Expands Quality, Packaging, and Storage Capabilities at Tennessee Facility
Thursday, June 18, 2026
Alcami Corporation announced a series of strategic and operational investments at its Tennessee facility, which was recently added to the company’s ... read more
WuXi Biologics' Suzhou Biosafety Testing Center Receives Fourth EMA GMP Certification
Thursday, June 18, 2026
WuXi Biologics announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by the ... read more
Mabion Reactivates MabionCD20 Through Rare Disease Collaboration with Oddifact
Thursday, June 18, 2026
Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance ... read more
Neuland to Open $20M Dedicated Process Development Facility with Integrated Kilo Labs in Hyderabad
Tuesday, June 16, 2026
Neuland Laboratories will open a dedicated process development laboratory and integrated kilo lab at its Genome Valley campus in Hyderabad. read more